Evaluation of Hemostasis in Bleeding and Thrombotic Disorders

Launched by THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER, HOUSTON · Sep 12, 2005

Keywords

ClinConnect Summary

This clinical trial is studying how well the blood coagulation system works in people with different bleeding and clotting disorders. Researchers will use special tests, including a device called the ROTEG analyzer and a thrombin generation assay, to examine how the blood clots in individuals with conditions that either cause excessive bleeding or lead to unwanted blood clots. The goal is to better understand these disorders and improve treatment options.

The trial is open to participants of all ages, from infants to older adults, who have either a congenital (present at birth) or acquired (developed later in life) bleeding or thrombotic disorder. However, individuals with poor venous access, meaning they have difficulty getting blood drawn, may not be eligible to participate. If you join the trial, you can expect to undergo some blood tests to help researchers gather important data. This study aims to enhance our understanding of blood coagulation and potentially lead to better care for those affected by these conditions.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria: patients with congenital or acquired bleeding or clotting disorders who have provided informed consent and/or assent
• • Exclusion Criteria: poor venous access